Eric Levenson PhD U.S. FDA
Eric Levenson PhD U.S. FDA Biological Reviewer, OTP, CBER
Eric is a biological reviewer in the Office of Gene Therapy/ Office of Therapeutic Products (OTP)/ CBER. He reviews a wide range of direct acting gene therapy products including DNA, RNA, or peptide therapeutics delivered by nanoparticles carriers, oncolytic viruses, and cancer active immunotherapies. An interdisciplinary scientist, he has degrees in chemistry and biochemistry (M.S., Ph.D. University of Delaware) and publlished with extensive training in virology, immunology, and chemical biology. Prior to joining OTP, he was a reviewer of allergenic products and conducted basic research on host IFN response to viral infection in OVRR/CBER.